SCI时时刷

search
The effects of remdesivir on mortality and the requirement for mechanical ventilation in ...
1. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlle...
Could histologic healing be a new treatment target in patients with ulcerative colitis?
Ulcerative colitis (UC) is one of the inflammatory bowel diseases (IBDs), all of which are characterized by chronic relap...
Now is the time to consider reducing the total ischemic time
The global prevalence of ischemic heart diseases, such as angina pectoris and myocardial infarction, ranks them among the...
Long term management of people with post-tuberculosis lung disease
1. Wordl Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022. 2. Iseman MD. Tub...
Biomarkers of the relationship of particulate matter exposure with the progression of chronic ...
1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framewo...
Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of ...
1. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet 2013;381:1943–1955. 2. Moorman AV. The clin...
Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: ...
1. Fasano S, Milone A, Nicoletti GF, Isenberg DA, Ciccia F. Precision medicine in systemic lupus erythematosus. Nat Rev R...
Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T ...
1. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s ly...
Metabolic syndrome awareness in the general Korean population: results from a nationwide survey
INTRODUCTION Metabolic syndrome is recognized globally as a significant public health concern. It is characterized by a c...
Model for end-stage liver disease-3.0 vs. ...
Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea ...
Duration of corticosteroid treatment in hospitalized COVID-19 patients, less is more
Dear Editor, We have read with great interest the paper by Kim et al. [1] who reported improved survival and no increase ...
Relationship between metformin use and mortality in tuberculosis patients with diabetes: a ...
2. Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review an...
New targets for type 2-low asthma
2. Cao TBT, Quoc QL, Yang EM, et al. Tissue inhibitor of metalloproteinase-1 enhances eosinophilic airway inflammation i...
The combined use of anti-peptic agents is associated with an increased risk of osteoporotic ...
1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health...
Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide ...
1. Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med (...
Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy ...
1. Asciak R, Rahman NM. Malignant pleural effusion: from diagnostics to therapeutics. Clin Chest Med 2018;39:181–193. 2....
Association of epicardial adipose tissue with metabolic risk factors on cardiovascular ...
INTRODUCTION Accumulation of adipose tissue, especially in the visceral cavity, plays an essential role in the developmen...
Navigating the risks of using concomitant antipeptic agents in light of osteoporotic concerns
Antipeptic medications, including proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs), are among the most c...
Metformin and tuberculosis: extraordinary stories of ordinary co-prevalent patients
Tuberculosis (TB) continues to be a major global health issue, causing millions of deaths annually [1]. The increasing pr...
Effects of aging on accompanying intermittent hypoxia in a bleomycin-induced pulmonary fibrosis ...
1. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respi...
Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study
1. Segawa K, Arisawa T, Niwa Y, et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonograph...
Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Hea...
Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid ...
1. Wheater G, Hogan VE, Teng YK, et al. Suppression of bone turnover by B-cell depletion in patients with rheumatoid arth...
Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous ...
1. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk fac...
Genetic susceptibility to post-endoscopic retrograde cholangiopancreatography pancreatitis ...
1. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004;59:845–864...
Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using ...
Rituximab is a monoclonal antibody that targets the CD20 B-cell antigen and is the standard first-line treatment for diff...
Factors influencing occurrence of metachronous gastric cancer after endoscopic resection: a ...
1. Lee SH, Park YW, Choe JY, et al. Gastrointestinal risk factors and patient-reported outcomes of ankylosing spondylitis...
Could assessment of genetic susceptibility be an effective solution to prevent pancreatitis ...
Endoscopic procedures, particularly endoscopic retrograde cholangiopancreatography (ERCP), play a crucial role in the suc...
Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of ...
1. Antonia SJ, Villegas A, Daniel D, et al.; PACIFIC Investigators. Overall survival with durvalumab after chemoradiother...
Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
1. Nangalia J, Green AR. Myeloproliferative neoplasms: from origins to outcomes. Blood 2017;130:2475–2483. 2. Hassel...